Linaglip

Linaglip

linagliptin

Manufacturer:

Aristopharma

Distributor:

KTZ
Concise Prescribing Info
Contents
Linagliptin
Indications/Uses
Monotherapy or in combination w/ other common antidiabetic medications including metformin, sulfonylurea, pioglitazone or insulin, as an adjunct to diet & exercise to improve glycemic control in adults w/ type 2 DM. Replacement therapy when metformin is not appropriate due to intolerance or does not provide adequate glycemic control, as monotherapy, or when other antidiabetic drugs are to be discontinued due to renal or hepatic impairment.
Dosage/Direction for Use
5 mg once daily. Combination w/ metformin: Maintain metformin dose to be given concomitantly. Combination w/ sulfonylurea: Consider lower sulfonylurea dose to reduce risk of hypoglycemia.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Do not use in patients w/ type 1 DM or for the treatment of diabetic ketoacidosis. Pregnancy & lactation. Childn <18 yr.
MIMS Class
ATC Classification
A10BH05 - linagliptin ; Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.
Presentation/Packing
Form
Linaglip FC tab 5 mg
Packing/Price
2 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in